Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if a drug called nebivolol can reverse inappropriate
left ventricular mass (LVM) when compared to the standard of care drug metoprolol.